Anti-Lymphoma Monoclonal Antibodies: Making Better Antibodies and Making Antibodies Better.

Monoclonal antibodies (mAbs) are highly effective anti-cancer agents; however, there is still considerable room for improving their therapeutic impact. Understanding the mechanisms of action of anti-cancer mAbs, and modifying mAb structure based on this understanding, is leading to the design and testing of more effective mAbs.